Yu S, Friedman Y, Richman R, Burke G
J Clin Invest. 1976 Mar;57(3):745-55. doi: 10.1172/JCI108333.
We studied the effect of thyroid hormone administration on responsivity of murine thyroid to exogenous thyrotropin (TSH) in order to explore the possibility that the thyroid gland might be directly inhibited by its own hormones. In the rat both L-thyroxine (T4) and 3,5,3'-L-triiodothyronine (T3) pretreatment inhibited TSH-induced thyroidal ornithine decarboxylase (ODC) activity in vivo in a dose-related manner (half-maximal inhibition, 1.7 mug/rat and 0.6 mug/rat, respectively). Other structurally related compounds exhibited the following inhibitory potencies compared to T4: T3, 283%; triiodothyroacetic acid, 40%; D-T4, 18%; 3,5-L-diiodothyronine, 9%. Monoiodotyrosine, diiodotyrosine, and iodide were not inhibitory. The full inhibitory effect of T4 or T3 was observed when thyroid hormone was administered from 96 to 12 h before TSH and was also seen in hypophysectomized animals. Pretreatment with T4 or T3 in divided doses over 2 1/2 days inhibited TSH-induced increase in [1-14C]glucose oxidation to 14C02 and [3H] leucine incorporation into protein in rat thyroid. In the mouse T4 or T3 pretreatment (0.25-25 mug daily) caused dose-related inhibition of both thyroidal ODC activity and 131I release induced by TSH in vivo. In mice on a low-iodine diet (LID) but not in animals on a regular diet (RD) NaI pretreatment also blunted TSH-induced thyroidal ODC activation and 131I release. When LID or RD mice were pretreated with 12.5-125 mug of T4 or T3 over 2 1/2 days, TSH-induced in vitro stimulation of thyroid cyclic 3',5'-adenosine monophosphate formation was inhibited in a dose-related manner; NaI pretreatment was inhibitory in the LID mouse only. Prior administration of exogenous TSH blunted the activation of thyroid ODC and thyroid hormone release induced by subsequent TSH administration in rat and mouse. These studies indicate altered thyroid responsivity to TSH under the influence of circulating thyroid hormones and suggest the existence of a "short-loop" negative feedback regulating thyroid function.
我们研究了给予甲状腺激素对小鼠甲状腺对外源性促甲状腺激素(TSH)反应性的影响,以探讨甲状腺可能受到自身激素直接抑制的可能性。在大鼠中,L-甲状腺素(T4)和3,5,3'-L-三碘甲腺原氨酸(T3)预处理均以剂量相关的方式在体内抑制TSH诱导的甲状腺鸟氨酸脱羧酶(ODC)活性(半数最大抑制剂量分别为1.7μg/只大鼠和0.6μg/只大鼠)。与T4相比,其他结构相关化合物表现出以下抑制效力:T3为283%;三碘甲腺乙酸为40%;D-T4为18%;3,5-L-二碘甲腺原氨酸为9%。一碘酪氨酸、二碘酪氨酸和碘化物无抑制作用。当在给予TSH前96至12小时给予甲状腺激素时,可观察到T4或T3的完全抑制作用,在垂体切除的动物中也可见到这种作用。在2.5天内分剂量用T4或T3预处理可抑制TSH诱导的大鼠甲状腺中[1-14C]葡萄糖氧化为14CO2以及[3H]亮氨酸掺入蛋白质。在小鼠中,T4或T3预处理(每日0.25 - 25μg)可在体内剂量相关地抑制TSH诱导的甲状腺ODC活性和131I释放。在低碘饮食(LID)的小鼠中,而非正常饮食(RD)的动物中,碘化钠(NaI)预处理也可减弱TSH诱导的甲状腺ODC激活和131I释放。当LID或RD小鼠在2.5天内用12.5 - 125μg的T4或T3预处理时,TSH诱导的甲状腺环磷腺苷(cAMP)形成的体外刺激以剂量相关的方式受到抑制;NaI预处理仅在LID小鼠中有抑制作用。预先给予外源性TSH可减弱随后给予TSH诱导的大鼠和小鼠甲状腺ODC激活和甲状腺激素释放。这些研究表明在循环甲状腺激素的影响下甲状腺对TSH的反应性发生改变,并提示存在调节甲状腺功能的“短反馈环”负反馈机制。